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Nonulosonic acids (NulOs),4 which include the sialic acids,
are a family of nine carbon ␣-keto sugars that serve as critical
recognition elements between cells. The most common sugar,
N-acetylneuraminic acid (Neu5Ac) (otherwise known as sialic
acid) (1), is found in most lineages of metazoans and performs a
wide range of functions in eukaryotes such as cell to cell communication (Fig. 1). Although these carbohydrates are utilized
by eukaryotes, bacteria can both biosynthesize and catabolize
sialic acid (1–5). The ability to catabolize sialic acid is widespread among both commensal and pathogenic species (3, 6).
Specifically, the catabolism of NulOs is an important phenotype for host–pathogen interactions (3, 6 –9). Certain bacteria
also utilize sialic acid to decorate their cell-surface structures
such as the lipopolysaccharide (LPS) and/or capsule polysaccharide (CPS) (10 –17). Sialic acids on the cell surface contribute to the evasion of the host immune response as a form of
molecular mimicry (18 –24).
Although sialic acid is found in eukaryotes and some prokaryotes, it is not the predominant NulO produced in bacteria.
Nine carbon ␣-keto sugars bearing a strong resemblance to
sialic acid such as derivatives from 5,7-diamino-3,5,7,9-tetradeoxy-non-2-ulosonic acids (Fig. 1; Fig. S1) have been characterized as prokaryote-specific NulOs. Traditionally, these prokaryote-specific NulOs are further categorized into one of
four classes of carbohydrates based on their stereochemistry:
pseudaminic, legionaminic (Leg), or two epimers of Leg, 4epi-legionaminic acid and 8-epi-legionaminic acid (25–27).
However, recent studies have described three new NulOs, specifically acinetaminic (Ace) and 8-epiacinetaminic acid found
in the CPS of Acinetobacter baumannii and fusaminic acid
(Fus) from the LPS of Fusobacterium nucleatum (Fig. S1) (28 –
30). The prokaryotic NulOs have been identified in various surface structures, including the LPS and CPS as well as N- and
O-linked glycans on flagella and pili (31–37). Although significant work has investigated the role of sialic acid in molecular
mimicry and host evasion, the chemical composition and
4

The abbreviations used are: NulO, nonulosonic acid; Leg5Ac7AcAla, 5-Nacetyl-7-N-acetyl-D-alanyl-legionaminic acid; Leg, legionaminic acid; Ace,
acinetaminic acid; Fus, fusaminic acid; PmB, polymyxin B; Leg5Ac7Ala, 5-Nacetyl-7-D-alanyl-legionaminic acid; DMB: 1,2-diamino-4,5-methylene
dioxybenzene; PG, peptidoglycan; LPS, lipopolysaccharide; CPS, capsule
polysaccharide; HR LCMS, high-resolution LC-MS; ESI, electrospray
ionization.
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Nonulosonic acids (NulOs) are a diverse family of ␣-keto acid
carbohydrates present across all branches of life. Bacteria biosynthesize NulOs among which are several related prokaryoticspecific isomers and one of which, N-acetylneuraminic acid
(sialic acid), is common among all vertebrates. Bacteria display
various NulO carbohydrates on lipopolysaccharide (LPS), and
the identities of these molecules tune host–pathogen recognition mechanisms. The opportunistic bacterial pathogen Vibrio
vulnificus possesses the genes for NulO biosynthesis; however,
the structures and functions of the V. vulnificus NulO glycan are
unknown. Using genetic and chemical approaches, we show
here that the major NulO produced by a clinical V. vulnificus
strain CMCP6 is 5-N-acetyl-7-N-acetyl-D-alanyl-legionaminic
acid (Leg5Ac7AcAla). The CMCP6 strain could catabolize
modified legionaminic acid, whereas V. vulnificus strain YJ016
produced but did not catabolize a NulO without the N-acetyl-Dalanyl modification. In silico analysis suggested that Leg5Ac7
AcAla biosynthesis follows a noncanonical pathway but appears
to be present in several bacterial species. Leg5Ac7AcAla contributed to bacterial outer-membrane integrity, as mutant strains
unable to produce or incorporate Leg5Ac7AcAla into the LPS
have increased membrane permeability, sensitivity to bile
salts and antimicrobial peptides, and defects in biofilm formation. Using the crustacean model, Artemia franciscana,
we demonstrate that Leg5Ac7AcAla-deficient bacteria have
decreased virulence potential compared with WT. Our
data indicate that different V. vulnificus strains produce
multiple NulOs and that the modified legionaminic acid
Leg5Ac7AcAla plays a critical role in the physiology, survivability, and pathogenicity of V. vulnificus CMCP6.

Modified legionaminic acid in bacterial lipopolysaccharides

Figure 1. Nonulosonic acids are a structurally diverse family of carbohydrates present on the surface of cells across all branches of life. These
carbohydrates play a critical role in various cell communications and host–pathogen interactions. This work describes a prokaryote-specific nonulosonic acid
(Leg5Ac7AcAla) in the lipopolysaccharide of the marine pathogen V. vulnificus, which is required for its survivability.
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demonstrate that the modified Leg, 5-N-acetyl-7-D-alanyl-legionaminic acid (Leg5Ac7Ala), lacking an acetyl group, is
catabolized via the canonical sialic acid pathway. Further analysis of deletion mutants demonstrate that biosynthesis of the
acetylated D-alanine carbohydrate is essential for outer membrane integrity, stress survival, and virulence in the brine
shrimp model Artemia franciscana.

Results
V. vulnificus CMCP6 biosynthesizes a modified legionaminic
acid
To begin to determine the structure of V. vulnificus NulOs
embedded in the sequence and genomic organization of the
biosynthesis pathways, we first investigated whether the NulO
biosynthesis genomic loci were homologous to previously
characterized pathways. The predicted biosynthesis operon of
strain CMCP6 was similar in gene arrangement and amino acid
composition with the biosynthetic region from Escherichia coli
O161 (Fig. 2B). Specifically, the Nab1, Nab2, and Nab3 proteins
of CMCP6 shared 54, 81, and 73% amino acid identity
with Lea7, Lea4, and Lea5 of E. coli O161. The LPS from E.
coli O161 contains a 5-N-acetyl-7-D-alanyl-legionaminic acid
(Leg5Ac7Ala) (43). The Leg5Ac7Ala is modified with a D-alanine at C-7 compared with the typical acetamido group in
legionaminic acid (Fig. 2C). Interestingly, the operon of
CMCP6 contained a putative N-acetyltransferase (i.e. nab5),
which was absent from the E. coli operon (Fig. 2B). We hypothesized that this N-acetyltransferase would acetylate the free
amine of the D-alanine, resulting in a NulO with a 7-N-acetylD-alanyl modification at C-7 (Fig. 2C). To determine whether
CMCP6 does in fact produce this modified Leg, the NulOs were
released from CMCP6 via mild acid hydrolysis in 2 N acetic acid,
derivatized with the fluorescent molecule 1,2-diamino-4,5methylene dioxybenzene (DMB), and separated via HPLC as
described previously (Fig. 3A) (41, 44). The major NulO peak
eluted at ⬃17 min (Fig. 3B). The derivatized NulO was collected
and analyzed by electrospray ionization MS (ESI-MS). The
[M ⫹ H]⫹ of 522.17 m/z as well as the [M ⫹ Na]⫹ of 544.21 m/z
from the NulO peak were consistent with the predicted modification that corresponds to a derivatized NulO modified with
acetylated alanine (Leg5Ac7AcAla) (Fig. 3C).
To characterize in more detail the native NulO structure, the
LPS of WT CMCP6 was purified via the hot water/phenol
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role of bacteria-specific NulOs in host–pathogen interactions
remain under-explored. In addition to the seven isomers of the
prokaryote-specific NulOs described, these carbohydrates can
display various functionalized N- and O-substitutions such as
acetylation. These diverse modifications may further contribute to multiple pathogen– host interaction mechanisms in vivo
and in the environment (38). The wide array of structural variants and the newest discoveries Ace and Fus motivated our
efforts to discover unique functional groups and novel isomers
within the model organism Vibrio vulnificus.
Previous work from our group confirmed that strains of
V. vulnificus, a marine bacterium and human opportunistic
pathogen, produced NulOs; however, the genomic region
responsible for the NulO biosynthesis was highly variable
within the species (Fig. 2A) (39). One study fully elucidated the
inner core of the LPS from the V. vulnificus strain ATCC 27562,
which was found to have pseudaminic acid as a carbohydrate
component (40). Biochemical analysis of V. vulnificus strains
with divergent NulO biosynthetic loci revealed that highly variable levels of NulO were produced depending on the genotype;
however, no detailed NulO structural information was elucidated (39). Two V. vulnificus strains in particular, CMCP6 and
YJ016, were studied in more detail. These two strains are nearly
identical; however, the NulO biosynthetic region is unrelated
(Fig. 2A). V. vulnificus strains with the CMCP6-like NulO genes
produce ⬃100-fold more NulO than strains with the YJ016-like
genes (41).
Efforts from our laboratory to connect the genetic NulO fingerprint with V. vulnificus pathogenicity revealed that NulOdeficient mutants have significantly increased sensitivity to the
bacterial antimicrobial peptide polymyxin B (PmB), defects in
swimming and biofilm formation, and are attenuated in a
mouse bloodstream model of infection (41). The extent of bacterial bloodstream survival and dissemination was proportional
to the amount of NulO expressed by the WT strain (NulO
expression: CMCP6 ⬎⬎ YJ016) (41). In addition, V. vulnificus,
mutants in the NulO biosynthetic pathway were defective in
virulence (42).
Given the correlation between NulO display and bacterial
pathogenesis, we chemically characterized the carbohydrate
biosynthesized in strain CMCP6, which produces higher levels
of NulO (39, 41). We found that a modified legionaminic acid is
produced in strain CMCP6, with an N-acetyl-D-alanyl group at
C-7 (Leg5Ac7AcAla, Fig. 1). Through gene deletion analysis, we

Modified legionaminic acid in bacterial lipopolysaccharides

method (45), and the NulO was released from purified LPS of
CMCP6 in 6% acetic acid for 4 h at 100 °C. The hydrolysate was
separated by size-exclusion chromatography. The fractions
containing NulOs, as indicated by staining with p-anisaldehyde
via thin-layer LC (TLC), were collected and analyzed via highresolution LC–MS (HR LCMS) to confirm the presence and
identity of the native carbohydrate (Fig. 4). The expected ionization pattern for the native NulO (Leg5Ac7AcAla) was confirmed via HR LCMS to include the dehydrated mass [M ⫺
18]⫹ of 388 m/z, [M ⫹ H]⫹ of 406 m/z, and [M ⫹ Na]⫹ of 428
m/z (Fig. 4).
Detailed structural 1H NMR and 13C NMR analyses were
conducted on the native NulO (Leg5Ac7AcAla) fractions. 460
mg of LPS was purified from 45 liters of culture, and the LPS
was hydrolyzed in acetic acid to release the NulOs, which were
further purified for NMR characterization in D2O (Fig. S2,
A–D). The NMR analysis revealed the presence of the corresponding CH3 of the alanine functionality upfield (⬃1.5 ppm)
from hydrogens attached to ␣-carbon downfield (⬃3.9 ppm) as
indicated via 2D 1H NMR analysis (Fig. S2, C and D). These
signature chemical shifts confirmed that the NulO produced by
V. vulnificus CMCP6 contained an alanyl functionality. In tan-

dem with the MS data and genomic analysis, the NulO structure was determined to be 5-N-acetyl-7-N-acetyl-D-alanyl-legionaminic acid (Leg5Ac7AcAla) (Fig. 2C).
Catabolism of 5-N-acetyl-7-D-alanyl-legionaminic acid in
V. vulnificus CMCP6
Our previous studies demonstrated that there are variable
amounts of NulO produced depending on the genotype of
V. vulnificus strains. In particular, strain CMCP6 produces 100fold more NulO than YJ016 under the same culture conditions
(Fig. 5, A and B) (41). When characterizing the biosynthetic loci
of these strains, the ⌬nab1 deletion resulted in the opposite
phenotype in which YJ016 produced more NulO than CMCP6.
The Nab1 enzyme is a cytidine monophosphate (CMP)–NulO
synthetase and catalyzes the transfer of CMP from CTP to activate the NulO for use by a downstream glycosyltransferase,
ultimately linking the sugar to LPS (46). No detectable NulO
was observed in the HPLC analysis of DMB-derivatized total
cellular fractions of the CMCP6 ⌬nab1 mutant (Fig. 5C), suggesting that the Leg5Ac7AcAla is catabolized by this strain.
Conversely, in the YJ016 ⌬nab1 we observe accumulation of a
NulO eluting at ⬃14 min, which suggests that this carbohyJ. Biol. Chem. (2018) 293(49) 19113–19126
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Figure 2. Nonulosonic acid biosynthesis loci are nonhomologous between V. vulnificus strains. A, predicted NulO biosynthetic genomic regions were
identified in V. vulnificus isolates via protein BLAST analysis. The regions were downloaded from the genome database and compared with EasyFig. B, BLASTp
analysis of the proteins encoded in strain CMCP6 identified the region and shares homology with the previously described biosynthetic loci of E. coli O161. C,
canonical Leg along with Leg5Ac7Ala of E. coli O161 and the predicted Leg5Ac7AcAla of CMCP6. Arrows represent open reading frames, and grayscale between
operons represents amino acid homology. Genes encoding proteins predicted to carry out similar functions are colored similarly.

Modified legionaminic acid in bacterial lipopolysaccharides
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Figure 3. Confirmation of predicted structure in CMCP6 by HPLC and mass spectrometry. A, derivatization reaction of acid released NulOs with the
fluorescent molecule DMB. B, nonulosonic acids were derivatized with DMB and separated by reverse-phase HPLC, and absorbance was measured at 373 nm.
C, separated DMB–NulOs were isolated and subjected to ESI-MS analysis. The major ion corresponds to the expected size [M ⫹ H]⫹ of 522 m/z and [M ⫹ Na]⫹
of 544 m/z consistent with the predicted structure.

19116 J. Biol. Chem. (2018) 293(49) 19113–19126
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Figure 5. Analysis of nab1 deletion mutants from V. vulnificus CMCP and YJ016. Total cellular fractions were derivatized with DMB, and the derivatized
NulOs were separated by HPLC monitoring absorbance at 373 from either WT CMCP6 (A), WT YJ016 (B), CMCP6 ⌬nab1 (C), or YJ016 ⌬nab1 (D).

drate is not catabolized (Fig. 5D). Mass spectrometry analysis of
the derivatized NulO revealed the accumulation of an unfunctionalized NulO such as legionaminic or pseudaminic acid (Fig.
S3, A and B).
Because Leg5Ac7AcAla does not appear to accumulate in the
CMCP6 ⌬nab1 strain, the carbohydrate might be catabolized
further within the cell. Previous work from our group has demonstrated the genes required for sialic acid transport and catabolism are lineage-specific within V. vulnificus and that CMCP6

can utilize sialic acid as a sole carbon and energy source (Fig.
S4A) (47). Therefore, a double deletion mutant of ⌬nanA/
⌬nab1 in which the first sialic acid catabolic enzyme, N-acetylneuraminate lyase (NanA), is deleted along with ⌬nab1 would
be predicted to cause the accumulation of Leg5Ac7AcAla
within the cell (Fig. 2C and Fig. S4B). The single ⌬nanA deletion
mutant produced Leg5Ac7AcAla in similar amounts to WT
CMCP6, and this mutant also accumulates sialic acid from
the medium inside the cell (Fig. S4C). However, the DMB
J. Biol. Chem. (2018) 293(49) 19113–19126
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Figure 4. High-resolution MS analysis of purified nonulosonic acid from V. vulnificus CMCP6. The modified nonulosonic acid was released from purified
LPS via mild acid hydrolysis in 6% acetic acid, separated by size-exclusion chromatography, and then analyzed by HR MS of separated modified-NulO from
CMCP6 LPS.

Modified legionaminic acid in bacterial lipopolysaccharides
Proposed biosynthesis pathway for Leg5Ac7AcAla

Membrane integrity of nonulosonic acid mutants

Figure 6. Catabolism of Leg5Ac7Ala in V. vulnificus CMCP6. Total cellular
fractions were derivatized with DMB and separated by HPLC, and absorbance
was measured for CMCP6 ⌬nanA/⌬nab1 (A). B, derivatized NulOs were collected and analyzed by ESI-MS revealing a mass of [M ⫹ H] of 479 corresponding to the loss of an acetyl group compared with WT. C, schematic of the
accumulation of Leg5Ac7Ala in the ⌬nanA/⌬nab1 double mutant of V. vulnificus CMCP6.

derivatization of the total cellular fractions of the CMCP6
⌬nanA/⌬nab1 followed by HPLC revealed the accumulation of
a different NulO molecule, as the HPLC retention time and
signal intensity were different from what was shown for
Leg5Ac7AcAla (Figs. 2C and 6A). Mass spectrometry analysis
of this molecule accumulating within the ⌬nanA/⌬nab1
mutant revealed a mass of [M ⫹ H]⫹ 480.2 m/z, 42 less than
WT Leg5Ac7AcAla corresponding to the loss of an acetyl
group from the sugar (Fig. 6B). This result shows that 5-Nacetyl-7-D-alanyl-legionaminic acid (Leg5Ac7Ala) can be
catabolized via NanA when Nab1 is inactivated (Fig. 6C).

19118 J. Biol. Chem. (2018) 293(49) 19113–19126

NulO mutants have increased sensitivity to antimicrobial
peptides, specifically PmB (Fig. S5) (41, 48). To determine
whether PmB induces outer membrane permeability in the
NulO mutant, a lysozyme permeability assay was utilized.
Under normal growth conditions, Gram-negative bacteria
exhibit resistance to lysozyme, an enzyme that cleaves the carbohydrate units of bacterial peptidoglycan (PG), because the
LPS limits access to the PG layer (49). If the outer membrane
becomes permeabilized, the lysozyme can gain access to the PG
and cause cell lysis. Both the WT and ⌬nab2 deletion mutant,
producing no Leg5Ac7AcAla, were subjected to sub-lethal concentrations of both PmB and lysozyme in combination, and the
optical density was measured for cell lysis. Under these conditions, the ⌬nab2 mutant cells lysed significantly more than WT
(Fig. 8A). This result indicates that the PmB is acting synergistically by permeabilizing the outer membrane of the ⌬nab2
mutant, allowing lysozyme to cause cell lysis, whereas the WT
remains unaffected. Previously, we demonstrated that complementation with a functional nab2 gene in ⌬nab2 restores
Leg5Ac7AcAla biosynthesis, although not back to WT levels
(41). We evaluated the ⌬nab2 complement strain for sensitivity
to PmB-induced membrane permeability, and we found the
defect was rescued compared with the ⌬nab2 mutant, albeit not
to WT levels, likely due to insufficient Leg5Ac7AcAla production (Fig. 8A). To further assess the membrane integrity under
physiologically relevant conditions, we performed survival
assays in 15% sodium choleate, a bile salt with a detergent-like
mechanism of action. CFUs were determined 0, 30, and 60 min
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Based on the data presented and the previously reported biosynthetic pathways (43, 46), we propose an eight-step pathway
for the production of the Leg5Ac7AcAla in V. vulnificus
CMCP6 (Fig. 7, A and B). In this model, the biosynthesis of
Leg5Ac7AcAla proceeds with several key differences from what
has been described for Leg (46). The addition of the D-alanine is
predicted to be catalyzed by Nab4 (VV1_0809), which is annotated as an N-acetyltransferase. Nab4 contains a partial N-acyltransferase superfamily domain, which includes a broad class
of enzymes catalyzing various acylation reactions, including
amino acid modifications. We predict that Nab4 is the alanyltransferase due to the shared homology with Lea3 from E. coli
O161, which biosynthesizes the D-alanyl-legionaminic acid
(Fig. 2C).
In addition to the D-alanine modification, the second unique
step in this biosynthetic pathway is the acetylation of this alanine residue by the enzyme encoded by nab5 (VV1_0805).
Nab5 is a predicted N-acetyltransferase with a complete acetyltransf_3 domain, which specifically catalyzes N-acetylation
reactions. Our analysis of the ⌬nanA/⌬nab1 deletion mutant
demonstrated that Leg5Ac7Ala accumulates in the cell and is
lacking the second acetyl group when compared with WT
CMCP6 (Fig. 6). This result would suggest that the acetylation
reaction occurs after the addition of the nucleotide CMP by
Nab1, which was always considered the last step in canonical
NulO biosynthesis pathways (Fig. 7B).

Modified legionaminic acid in bacterial lipopolysaccharides

following exposure. The ⌬nab2 mutant exhibited an approximate log decrease in CFUs immediately following exposure
to bile salts, and this defect continued throughout the experiment (Fig. 8B). Together, these results indicate that the biosynthesis of Leg5Ac7AcAla and that the LPS modification by
Leg5Ac7AcAla are important for the outer membrane integrity
of V. vulnificus particularly in the presence of antimicrobial
peptides. The ⌬nab2 complement strain was evaluated for bile
sensitivity and shown to rescue the phenotype; however, the
strain was more resistant to sodium choleate compared with
WT CMCP6 (Fig. 8B). This result suggests that the decreased
levels of Leg5Ac7AcAla produced in the complement may be
more advantageous for choleate resistance in V. vulnificus
CMCP6.
Previously, we demonstrated that the ⌬nab2 mutant of
CMCP6 was attenuated in a mouse bloodstream model of
infection (41). Because of the effects to membrane integrity and
sensitivity in the presence of PmB, the ⌬nab2 mutant could be
defective in human serum, which contains the antimicrobial
complement cascade but lacks any immune cells. However, survival assays in total human serum were conducted, and CFUs
were measured over the course of 2 h post-exposure, and we
found that the ⌬nab2 mutant had no survival defect (Fig. S6A).
A translucent variant strain CMCP6/T lacking a capsule, previously shown to be essential for serum resistance (50), was
cleared after serum exposure for 30 min (Fig. S6A). All strains
were able to survive in heat-inactivated serum (Fig. S6B).
Leg5Ac7Ala contributes to biofilm formation
Previous work demonstrated that the ⌬nab2 mutant of
V. vulnificus CMCP6 was defective in biofilm formation, and
NulO biosynthesis has been implicated in biofilm formation in

several other bacteria (36, 41, 51–53). It was speculated that the
presence of NulO may contribute to the V. vulnificus biofilm
formation mechanism. A preliminary investigation into the
role of NulOs in biofilm was conducted utilizing crystal violet
staining. After 24 h, the ⌬nab1 mutant exhibited a decrease in
biofilm formation compared with WT CMCP6, which was
restored albeit not back to WT levels following nab1 complementation (Fig. 8C and Fig. S7). However, this defect was abolished in the ⌬nanA/⌬nab1 double deletion mutant, which
accumulates Leg5Ac7Ala within the cell (Fig. 8C). This result
suggests that the accumulation of Leg5Ac7Ala overrides the
original defect in biofilm formation, despite the inability to activate the carbohydrate with a CMP moiety (Fig. 8C, Fig. 2C). A
more detailed analysis is required to fully understand the composition and regulation of biofilm formation in these NulO
mutants of V. vulnificus.
Leg5Ac7AcAla mutants are attenuated in virulence toward
A. franciscana
Because of the conservation of nonulosonic acid biosynthesis
pathways within V. vulnificus, we speculated that these sugars
would be important for survival and/or pathogenesis in the
marine environment. A. franciscana is a model crustacean and
has previously been used to assess V. vulnificus virulence factors (54 –56). Here, the ability of WT CMCP6 and the ⌬nab1
and ⌬nab2 deletion mutants to kill A. franciscana nauplii was
examined. Artemia cysts were hatched in artificial seawater,
and subsequently, the nauplii were exposed to 1 ⫻ 106 CFUs of
either WT, nab mutants, or autoclaved CMCP6 control and
were monitored as alive or dead 24 and 48 h following exposure.
At the end of 2 days, there was a 21.7% survival rate of nauplii
that were infected with WT CMCP6. Comparatively, there
J. Biol. Chem. (2018) 293(49) 19113–19126
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Figure 7. Proposed biosynthesis pathway for Leg5Ac7AcAla within V. vulnificus CMCP6. A, CMCP6 Leg5Ac7AcAla biosynthesis operon. B, function of
enzymes within the pathway were assigned via homology analysis and biochemical characterizations of deletion mutant strains. The biosynthesis of
Leg5Ac7AcAla proceeds via an eight-step process, including a putative D-alanyltransferase (Nab4) and an N-acetyltransferase (Nab5) that functions following
CMP addition.

Modified legionaminic acid in bacterial lipopolysaccharides

was 59 and 57.7% survival for the ⌬nab1 and ⌬nab2 deletion
mutants, respectively (Fig. 8D). The WT CMCP6 was significantly more virulent toward the nauplii than the Leg5Ac7
AcAla null strains. However, these strains are more virulent
than the heat-killed bacteria control in which 85% of the nauplii
survived (Fig. 8D). Complementation of the ⌬nab1 and ⌬nab2
mutants with functional copies of nab1 or nab2 did not completely restore virulence potential as the nauplii exhibited a survival rate of 51.7% following exposure to these strains (Fig. 8D).
The inability to complement back to WT is likely due to the
insufficient Leg5Ac7AcAla production across the 48-h incubation time.

19120 J. Biol. Chem. (2018) 293(49) 19113–19126

Discussion
Nonulosonic acid chemistry and structural diversity are
expanding fields, with new isomers and modifications still
being discovered and characterized. These unique carbohydrates, key building blocks of LPS, are implicated in various
pathologies of virulent bacteria as well as their overall survivability. Here, we characterized the NulOs of the opportunistic
human pathogen V. vulnificus and found structural diversity
within the species. A modified legionaminic acid in the LPS of
strain CMCP6 was determined, Leg5Ac7AcAla (Figs. 2C and 4
and Fig. S2). Our previous work demonstrated that the nab
alleles of strain CMCP6 were present within a large number of
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Figure 8. Leg5Ac7AcAla biosynthesis supports outer membrane integrity in V. vulnificus CMCP6 and enables biofilm formation and virulence in brine
shrimp. A, polymyxin B induced membrane permeability. WT CMCP6, the ⌬nab2 deletion mutant, or the nab2 complement were subjected to both PmB (10
g/ml) and lysozyme (10 g/ml) in PBS or PBS alone. Cell lysis was monitored as a change in optical density (A595). B, bile salt survival assay. Survival assays of
WT CMCP6, the ⌬nab2 mutant, or the nab2 complement were performed in 15% sodium choleate, a bile salt. CFU were determined for each strain prior to
exposure and at 0, 30, and 60 min following exposure. C, biofilm formation of V. vulnificus strains. The strains were grown statically for 24 h in Marine broth at
room temperature. Biofilms were stained with 0.1% crystal violet and photographed, and the A was measured following resuspension in DMSO. Individual
points represent average biological replicates from six technical replicates. Lines indicate mean and S.D. D, A. franciscana model of infection. Artemia nauplii
were hatched in artificial seawater and exposed to 1 ⫻ 106 CFU of either WT CMCP6, ⌬nab1, ⌬nab2, the nab1 complement, the nab2 complement, or heat-killed
(HK) control CMCP6. Survival of the nauplii was determined at 24 and 48 h following exposure. Individual points represent independent experiments consisting
of three technical replicates. Bar graph indicates mean, and error bars represent S.D. Welch’s ANOVA with Games-Howell post-hoc analyses. * indicates p ⬍ 0.05.
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clinical isolates of V. vulnificus suggesting that this NulO is
prominent within this species (39). In addition, Leg5Ac7AcAla
is not limited to V. vulnificus, because bioinformatics analysis
identified homologous biosynthetic pathways in many other
bacterial species (Fig. 9). Included in this list are several fish
pathogens (such as Aliivibrio wodanis and Aeromonas popofii)
as well as the significant human pathogen Vibrio parahaemolyticus. Indeed, Leg5Ac7AcAla was identified in the LPS of an
O-untypeable strain of V. parahaemolyticus (57).
Deletion of key biosynthetic enzyme genes suggested that
acetylation of the alanyl group occurs after the addition of the
CMP sugar carrier. The activation with CMP is typically considered the final step of the NulO biosynthesis prior to incorporation into the downstream structures. We propose that
V. vulnificus utilizes a post-CMP–NulO modification strategy
in which the free amine of the D-alanine is acetylated. Interestingly, previous work has proposed other modifications of
NulOs that occur on the CMP-NulO in Campylobacter jejuni
(58).
The genomic regions encoding the NulO biosynthetic pathway in V. vulnificus strains CMCP6 and YJ016 are highly variable in gene content and arrangement with very little shared
homology. The lack of nab4 and nab5 homologs in YJ016 indicates that the N-acetyl-D-alanyl NulO modification does not
occur in this strain. The biochemical analysis of the NulO of
YJ016 via HPLC and ESI-MS indicates that this carbohydrate is
of the di-N-acetylated variety characteristic of bacterial NulOs
without any further modifications. Furthermore, this carbohydrate is possibly a stereoisomer other than Leg, due to the
inability of this NulO to be catabolized by the sialic acid catabolism pathway and NanA.

The Leg5Ac7Ala NulO can be catabolized via the sialic acid
degradation pathway in V. vulnificus CMCP6 (Fig. 6). This finding is of particular interest as the ability to utilize sialic acid as a
nutrient has been implicated in host colonization in various
pathogens (6, 7, 9). Previously, we demonstrated that sialic acid
catabolism enhances colonization by Vibrio cholerae (6, 7). We
showed that sialic acid catabolic pathways are largely associated
with mucosa-associated commensals and pathogens (3, 6, 7).
Both Leg5Ac7AcAla and sialic acid have the same stereochemistry in the carbohydrate core. Therefore, the sialic acid catabolic enzymes may exhibit substrate promiscuity and act on
Leg allowing catabolism of these prokaryotic NulOs as we
have demonstrated here with NanA of V. vulnificus. Further
research is required to determine whether prokaryote-specific
NulOs such as Leg can be scavenged from diverse microbial
populations and utilized as an exogenous energy source contributing to niche expansion.
The NulO biosynthetic mutants have increased sensitivity to
the antimicrobial peptide PmB, which is also able to permeabilize the membrane of the mutants compared with WT. We
predicted that the defect in membrane integrity in the presence
of PmB could explain our previous work, which showed that
these mutants are readily cleared by the immune system in vivo
(41). However, we found here that these same mutants are not
sensitive to human serum in vitro, suggesting there is something present in vivo, beyond the antimicrobial activity of the
complement cascade, that is responsible for the clearing of the
NulO-deficient strains. This result is further supported by a
recent study examining V. vulnificus YJ016 growth in serum
that found the NulO biosynthetic genes were not involved in
serum survival (59).
J. Biol. Chem. (2018) 293(49) 19113–19126
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Figure 9. Homologous Leg5Ac7AcAla biosynthetic genomic regions outside of V. vulnificus. Key NulO biosynthetic proteins were used as query to
identify the homologous pathways in bacteria outside of V. vulnificus. The genomic regions were downloaded and used for comparative genomics analysis.
The gray bars between coding regions represent amino acid homology. The ORFs predicted to catalyze similar reactions are colored the same. Figure was
created in EasyFig.
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Table 1
Strains and plasmids used in this study
Strain/plasmid
V. vulnificus strains
CMCP6
YJ016
JBL0803
JBL0808
NMD0730/0803
CMCP6/T
JBL20730
SAM0316
E. coli strains
DH5␣ pir
B2155 DAP

Clinical isolate
Clinical isolate
CMCP6 ⌬nab1 (VV1_0803)
CMCP6 ⌬nab2 (VV1_0808)
CMCP6 ⌬nanA/⌬nab1 (VV2_0730/VV1_0803)
Translucent colony morphology variant of CMCP6. Serum-sensitive
CMCP6 ⌬nanA (VV2_0730)
YJ016 ⌬nab1

Refs.
63
64
This study
41
This study
This study
This study
This study

Pir 80dlacZ⌬⌴15␦ (lacZYA-argF)U169 recA1 hsdR17 deoR thi-1 supE44 gyrA96 relA1
Donor for bacterial conjugation; thr-1004 pro thi strA hsdS lacZ⌬⌴15 (F lacZ⌬⌴15
lacTRQJ36 pro AB) dapA ermr pirRP4 (Kmr from SM10)
Expression vector; Cmr
Suicide plasmid; Cmr sacB
V. vulnificus nanA knockout vector (VV2_0730 SOE product)
V. vulnificus CMCP6 nab1 knockout vector (VV1_0803 SOE product)
V. vulnificus YJ016 nab1 knockout vector (VV0316 SOE product)
V. vulnificus nab1 complement expression (VV0803C PCR product)
V. vulnificus nab2 complement expression (VV0808C PCR product)

The conserved ability to produce NulOs within V. vulnificus
implies that these carbohydrates are essential for survival in the
aquatic reservoir. Naturally, V. vulnificus can be commensal
with phytoplankton, fish, and various crustaceans where in
some cases the bacteria can be pathogenic. We show that NulO
biosynthesis is required for virulence in the model crustacean
organism A. franciscana. One explanation for the decreased
virulence of the Leg5Ac7AcAla null strains is that there may be
antimicrobial peptides produced by the A. franciscana brine
shrimp which the NulO mutants are sensitive to resulting in
their attenuation. Additionally, the mutated carbohydrates of
LPS along with the fact that these strains are not fully motile
may affect binding to the chitinous surface of the shrimp resulting in decreased virulence.
The NulOs described here and their carbohydrate modifications are highly prokaryote-specific. Two genes, nab4 and
nab5, which putatively catalyze the addition of a D-alanine and
acetylation of D-alanine, respectively, are unique in that D-alanine is predominantly limited to bacteria. The distinctive functions of NulO-modifying enzymes such as Nab4 and Nab5 as
well as the significant role of NulOs in numerous pathogens
makes the NulO biosynthetic proteins promising targets for
antimicrobial therapies. Because of their prominence on surface structures, the NulO modifications such as the 7-N-acetylD-alanyl group described here can be targeted for vaccine
development.
We have demonstrated that genetic diversity at the nonulosonic acid biosynthesis loci within V. vulnificus results in
variable NulO structures ultimately altering the LPS. We chemically characterized a functionalized NulO, Leg5Ac7AcAla, in
the pathogenic strain V. vulnificus CMCP6 and showed that
modified legionaminic acid can be catabolized by the cell. Physiological characterizations of NulO mutants demonstrate how
these carbohydrates contribute to biofilm formation, membrane integrity, and virulence toward crustaceans. These findings contribute to the ongoing efforts toward deconvoluting the
production, structural elements, and processing of NulOs displayed by many species of bacteria. This information is critical
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65
66

This study
41

for understanding the role of NulOs in host–pathogen recognition, their potential as virulence factors, and as targets for
novel antimicrobial therapies.

Experimental procedures
Strains and culture conditions
This study utilized the V. vulnificus clinical isolates CMCP6
and YJ016. Strains and plasmids used are listed in Table 1. All
strains were grown aerobically at 37 °C in Lysogeny Broth (LB)
(ThermoFisher Scientific, Fair Lawn, NJ) containing 2% NaCl.
Strains were grown overnight from a single colony. Where indicated, overnight cultures were subcultured in fresh LB 2% to
obtain logarithmic growth. All strains used are resistant to
streptomycin, and where indicated, antibiotics were utilized at
the following concentrations: streptomycin 200 g/ml, chloramphenicol 25 g/ml.
Allelic exchange mutagenesis in V. vulnificus
V. vulnificus CMCP6 and YJ016 genome sequences were
used for primer design, and oligonucleotides were purchased
from Integrated DNA Technologies (Coralville, IA) and are
listed in Table 2. An in-frame deletion of CMCP6 nab2 was
created previously (41). In-frame nonpolar gene deletions of
nab1 in both strains CMCP6 and YJ016 were constructed via
splicing by overlap extension PCR and homologous recombination as described previously (60). Primers were designed to
amplify the regions flanking either CMCP6 VV1_0803 (nab1)
or YJ016 VV0316 (nab1). A double deletion strain of ⌬nanA/
⌬nab1 in CMCP6 was generated starting with a ⌬nanA background in which the nab1 gene was next deleted. Gene fragments were spliced together by PCR and complementary ends,
cloned into the suicide vector pDS132, and transformed into
the donor strain E. coli ␤2155. The donor strains were conjugated overnight with the recipient V. vulnificus strain. Strains
that had integrated the deletion vector into the genome via
homologous recombination were selected on LB 2% plates supplemented with chloramphenicol. Colonies were subsequently
grown overnight in LB 2% without selection and plated on LB

Downloaded from http://www.jbc.org/ at Washington University on November 18, 2019

Plasmids
pBBR1MCS
pDS132
pDS2_0730
pDS0803
pDS0316
pBBR0803
pBBR0808

Genotype/description
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Table 2
Primers used in this study
Sequence 5ⴕ–3ⴕ

SOEVV1_0803A
SOEVV1_0803B
SOEVV1_0803C
SOEVV1_0803D
SOEVV1_0803FF
SOEVV1_0803FR
SOEVV0316A
SOEVV0316B
SOEVV0316C
SOEVV0316D
SOEVV0316FF
SOEVV0316FR
SOEVV2_0730A
SOEVV2_0730B
SOEVV2_0730C
SOEVV2_0730D
SOEVV2_0730FF
SOEVV2_0730FR
VV1_0803FC
VV1_803RC
VV1_0808FC
VV1_0808FR

TCTAGAAAGCGTGCACAAGTGGATATTCTCA
AACGGCACCTCTGCCCCCGCT
AGCGGGGGCAGAGGTGCCGTTAAGCTCGGTTGATATTGACCATGAG
GAGCTCGCCCCACTCCACTTGCTGA
GATTACTTCGGTGGCGAAAG
GAATCAGGTAACGTGGTGCT
TCTAGAACGGCGCTTTCCAATCACATCGG
CACTATCGCGCCCGATGCAC
GTGCATCGGGCGCGATAGTGCCAAAAGAGCGAGCGGTGGATA
GAGCTCAGAAAGGCGTTCACGCATCGC
GCCCAAATGGGATAAAAACC
AGCTCGCAACAGCATAGCTT
TCTAGAAATCCGCATCGCGCATTTTC
AATTACGCTGCGCCACTGTA
TACAGTGGCGCAGCGTAATTATCAACGCCGAATGGAATATC
GAGCTCCTGATCGCCGCTCCTCATAC
TGCGAGGCACCTCTTTTTAT
GCTATTGCCTGAGCTGCTTT
AAGCTTAAGGTGAATAATCGAATGAAA
TCTAGACGGCAACAAGAATAGTTTTA
AAGCTTCGCAAGCACCAAAGTTATT
TCTAGAGTGGCGGTGACTACACAGATT

2% plates supplemented with 10% sucrose to select for the second round of homologous recombination. The double cross–
colonies were confirmed to be deletion mutants via PCR. Complement strains were generated similarly using primers listed in
Table 2 and cloned into the expression vector pBBR1MCS.
Complement strains were induced with 0.05 mM isopropyl
1-thio-␤-D-galactopyranoside.
DMB derivatization of V. vulnificus NulOs
V. vulnificus cultures were grown overnight in LB 2%. A
1:100 dilution was made from overnight cultures into LB 2%
NaCl, and cultures were grown for 4 h. Cells were pelleted and
washed in PBS. Bacterial pellets were resuspended in 4 ml of 2 N
acetic acid and incubated at 80 °C for 3 h as described previously (41, 44). Following the release of the NulOs via mild acid
hydrolysis, cell debris was removed via centrifugation, and the
soluble supernatant was passed through a 10-kDa molecular
mass cutoff filter. The low molecular mass fraction (flowthrough) containing NulOs was then derivatized with DMB
(Dojindo Molecular Technologies), as described previously (39,
44). In brief, the reaction consisted of 1.4 mM acetic acid, 0.7 M
2-mercaptoethanol, 18 mM sodium hydrosulfite, and 7 mM
DMB incubated in the dark at 50 °C for 2 h.
TLC of separated NulOs
Thin layer chromatography (TLC) in which glass plates
coated with silica gel (250 m, Silica Gel HL, Sorbent Technologies) were used and visualized with shortwave 254 nm UV
light or developed upon heating with p-anisaldehyde.
HPLC and MS analysis of V. vulnificus NulOs
Analytical and semi-preparative HPLC was performed on an
Agilent Series 1100 using a Phenomenex威 Luna 5-m C18 column (250 ⫻ 10.00 nm). Low-resolution mass spectra were
obtained on a Shimadzu LCMS 2020 or a Waters SQD2 instrument using ESI. High-resolution mass spectra (HR-MS), ESI
mode, were obtained on a ThermoFisher Scientific Q-Exactive

Product size
241
227
1063
251
224
1068
247
240
996
744
1079

Orbitrap at the Mass Spectroscopy Facility at the Department
of Chemistry, University of Delaware.
Nuclear magnetic resonance of purified NulOs
All NMR spectra were recorded on Bruker AV 400 MHz and
AV III 600 MHz spectrometers. Proton chemical shifts were
recorded in parts per million (ppm) on the ␦ scale, downfield
from tetramethylsilane and referenced from an internal standard of residual protium in the NMR solvents (HDO: ␦ 4.87).
Data for 13C NMR were reported in ppm downfield from
tetramethylsilane. NMR data were reported as follows: chemical shift, multiplicity (s ⫽ singlet, d ⫽ doublet, t ⫽ triplet, q ⫽
quartet, m ⫽ multiplet, and br ⫽ broad), coupling constant in
Hz, integration, and assignment based on two-dimensional
COSY, HSQC, and HMBC experiments. NMR processing was
done using MestReNova 2005–2017 Research SL Software.
Chemical shifts of Leg5Ac7AcAla are as follows: 1H NMR (600
MHz, deuterium oxide) ␦ 5.09 (s, 1H), 5.00 (d, J ⫽ 6.2 Hz, 1H),
4.94 – 4.84 (m, 3H), 4.52 (d, J ⫽ 10.8 Hz, 1H), 4.40 – 4.34 (m,
2H), 4.34 – 4.26 (m, 3H), 4.19 (ddt, J ⫽ 19.1, 12.5, 6.7 Hz, 5H),
4.11 (d, J ⫽ 6.2 Hz, 2H), 4.09 –3.93 (m, 9H), 3.86 (ddq, J ⫽ 15.8,
10.0, 5.9 Hz, 5H), 3.82–3.66 (m, 7H), 3.65–3.55 (m, 3H), 3.50
(dd, J ⫽ 11.8, 6.5 Hz, 1H), 3.23 (dd, J ⫽ 13.8, 5.8 Hz, 1H), 3.14 (t,
J ⫽ 7.8 Hz, 1H), 3.06 (t, J ⫽ 7.8 Hz, 1H), 2.11–2.00 (m, 14H), 1.98
(d, J ⫽ 25.1 Hz, 8H), 1.94 (d, J ⫽ 5.4 Hz, 7H), 1.32 (t, J ⫽ 6.5 Hz,
2H), 1.12 (s, 1H), 1.11 (d, J ⫽ 5.8 Hz, 4H); 13C NMR (101 MHz,
D2O) ␦ 174.92, 174.80, 173.95, 173.79, 173.64, 173.17, 98.94,
98.43, 94.10, 78.06, 75.62, 72.85, 72.62, 71.93, 70.69, 70.45,
70.30, 68.07, 67.02, 66.16, 65.76, 64.54, 63.68, 62.33, 53.52,
53.42, 52.27, 50.10, 49.80, 48.62, 48.07, 45.80, 44.55, 36.41,
36.23, 23.65, 21.99, 21.89, 21.80, 21.65, 21.31, 19.14, 16.86,
16.48, 15.18.
Purification of V. vulnificus lipopolysaccharide and isolation
of NulO
V. vulnificus cultures were grown overnight in LB 2%. Cells
were pelleted and washed in PBS followed by subsequent
washes in ethanol and acetone to dry the bacterial pellets.
J. Biol. Chem. (2018) 293(49) 19113–19126
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Lipopolysaccharide was isolated from dried bacterial pellets
using the hot water phenol method as described previously (45).
Pellets were resuspended in equal volumes of water and 90%
phenol at 70 °C with stirring for 30 min. All phases were dialyzed to remove residual phenol. Proteins and nucleic acid were
precipitated in 50% trichloroacetic acid (TCA) for 1 h at 4 °C.
The precipitate was removed by centrifugation, and the LPScontaining fraction was lyophilized. Nonulosonic acids were
removed by mild acid hydrolysis in 6% acetic acid for 3 h at
100 °C until a precipitate formed that was removed via centrifugation. The acid-hydrolyzed fraction was further separated via
size-exclusion chromatography on Sephadex G-25. NulO containing fractions were combined and used for NMR analysis.
Bacterial survival assays in sodium choleate and human
serum

A. franciscana model of infection
The A. franciscana infection model was carried out using
methods similar to those described previously (54 –56). In brief,
A. franciscana cysts (San Francisco Bay Brand ASF65031) were
hatched in artificial seawater at 28 °C with aeration in light for
36 h. The nauplii were separated into groups of 20 in 5 ml of
artificial seawater in 25-mm plates. V. vulnificus strains were
subsequently added to the A. franciscana nauplii at 1 ⫻ 106
CFU. The nauplii were visually screened and scored as dead or
alive at 24 and 48 h post-inoculation. The experiment was conducted in three biological replicates with three technical replicate plates of nauplii per biological replicate.
Lysozyme membrane permeability
The lysozyme permeability assay was carried out as described
previously (62). Exponential cells were washed and resuspended in PBS and either PmB (10 g/ml), lysozyme (10
g/ml), or both were added to the suspension. The bacterial
suspensions were added to a 96-well plate, and the optical density was measured every minute for 1 h with shaking for 10 s
prior to measurement using a Sunrise microplate reader and
MagellanTM plate reader software. Experiments were completed in triplicate wells with at least two biological replicates
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Exponential cells were washed and resuspended in PBS at an
A of ⬃0.5 and added to a 96-well plate. Polymyxin B was added
to a final concentration of 80 g/ml. Cell lysis was monitored as
a drop in optical density. The A595 was measured every 5 min
with 10 s of shaking prior to each measurement using a Sunrise
microplate reader and Magellan plate reader software. Experiments performed in triplicate and two biological replicates.
Biofilm assay
V. vulnificus strains were grown overnight in 2% LB. A 1:40
inoculum of the overnight cultures was used to inoculate
Marine broth in 96-well polystyrene plates (Corning Inc.,
CLS2593). Cultures were incubated statically at room temperature for 24 h allowing the biofilms to form. Following incubation, cultures were removed, and loosely adherent cells were
washed twice with 200 l of PBS. Biofilms were stained with
0.1% crystal violet for 30 min. The stain was removed, and biofilms were again washed twice with 200 l of PBS. The stained
biofilms were photographed and subsequently resuspended in
dimethyl sulfoxide (DMSO) to solubilize the biofilm. The optical density (A595) was measured for 1:10 diluted biofilms. Biofilm determinations were performed with six replicate wells
and three biological replicates.
Statistical analysis
Biological and technical replicates are indicated under
“Experimental procedures” and figure legends. The data were
analyzed by Welch’s ANOVA followed by a Games-Howell
post hoc test. Data are presented as mean values ⫾ S.D. A p ⬍
0.05 was considered significant.
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